about
Nanomilling of Drugs for Bioavailability Enhancement: A Holistic Formulation-Process Perspective.Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems--enhancement of oral bioavailabilityMechanochemical phosphorylation and solubilisation of β-D-glucan from yeast Saccharomyces cerevisiae and its biological activities.Towards improved solubility of poorly water-soluble drugs: cryogenic co-grinding of piroxicam with carrier polymers.An overview of famotidine polymorphs: solid-state characteristics, thermodynamics, polymorphic transformation and quality control.New composites of betulin esters with arabinogalactan as highly potent anti-cancer agents.The influence of secondary processing on the structural relaxation dynamics of fluticasone propionateDissolution properties and physical characterization of telmisartan-chitosan solid dispersions prepared by mechanochemical activation.Solubility Enhancement of a Poorly Water Soluble Drug by Forming Solid Dispersions using Mechanochemical ActivationInfluence of alkalizers on dissolution properties of telmisartan in solid dispersions prepared by cogrinding.Effect of processing history on the surface interfacial properties of budesonide in carrier-based dry-powder inhalers.Improvement in solubility and bioavailability of puerarin by mechanochemical preparation.Microwave-generated bionanocomposites for solubility and dissolution enhancement of poorly water-soluble drug glipizide: in-vitro and in-vivo studies.Cyclodextrin encapsulation of daidzein and genistein by grinding: implication on the glycosaminoglycan accumulation in mucopolysaccharidosis type II and III fibroblasts.An effect of cellulose crystallinity on the moisture absorbability of a pharmaceutical tablet studied by near-infrared spectroscopy.Preparation, characterizations and anti-pollutant activity of 7,3′,4′-trihydroxyisoflavone nanoparticles in particulate matter-induced HaCaT keratinocytes.Morphological Investigation and Fractal Properties of Realgar Nanoparticles
P2860
Q26746912-F0767C22-FF95-44C8-B6AE-AF494E018E30Q30407466-C3BDCE70-C8D3-4CEF-AD05-8F0EDC168C26Q30839544-3B23D379-99D9-4C1D-B4C2-BFE7FE4BEBB0Q35660913-20A56A22-0DA5-45EB-BDEB-577338D988F1Q38191851-B74EFE69-00C1-49B4-92D0-C9B7DF1C0F67Q38854022-973BB838-3DD3-4CA5-8322-50BF1CB6791DQ41110000-C6FC28C8-11B4-4D8A-90E5-4463D29AEA20Q41123195-D31999A3-88FD-44F6-865C-01AEF9BC2DD6Q42796371-C77B75B6-47E4-4A71-AE4C-5776BB34714AQ44052176-091C69F3-3B9F-4D8D-8BF4-648147689044Q44374500-8284EE8E-37F3-4844-9F24-EE38CB67B80FQ44685497-9ADADBEF-9672-4750-A7B8-7217F8A83C8BQ46621988-EAB34303-7F61-482A-93AC-F3C752D564E2Q49714390-8B22320C-F53C-4489-B674-CEFC483BD5D8Q53060160-47D871F9-93D6-4BEB-9182-93C3837D8014Q55109237-CA6B65C0-8367-46C5-85B0-3D670A908177Q58058262-2EF36C92-6A7D-4AC1-8CD7-154420E8ED44
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Drug mechanochemical activation.
@en
Drug mechanochemical activation.
@nl
type
label
Drug mechanochemical activation.
@en
Drug mechanochemical activation.
@nl
prefLabel
Drug mechanochemical activation.
@en
Drug mechanochemical activation.
@nl
P2093
P356
P1476
Drug mechanochemical activation.
@en
P2093
P304
P356
10.1002/JPS.21733
P407
P577
2009-11-01T00:00:00Z